Breaking News

Sartorius Acquires Stake in AllPure Technologies

April 28, 2014

Expands portfolio of single-use components for biopharma applications

Sartorius Stedim Biotech (SSB) has signed a contract to acquire majority stake in AllPure Technologies LLC, a start-up company based in New Oxford, PA that specializes in single-use components for biopharma applications. AllPure was established in 2010, and in 2013 had revenues of approximately $3 million with 25 employees. Financial terms were not disclosed.
 
Reinhard Vogt, member of SSB’s executive board said, “AllPure further completes our portfolio with innovative products that help our customers develop and manufacture their pharmaceutical drugs safer and more efficiently. I am really looking forward to working with the AllPure team and to all that we can accomplish together.”
 
“We are excited to leverage Sartorius Stedim’s impressive R&D capabilities so that we can accelerate the launch of new products from AllPure. And SSB’s global reach and industry relationships grant access to considerably more customers, especially in Europe and Asia, which have tremendous potential for AllPure’s products,” said Michael Zumbrum, president of AllPure.

Related Packaging:

Related Contract Manufacturing:

Related Compliance:

blog comments powered by Disqus
  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Continuous Pharmaceutical Processes and Their Demands

    Continuous Pharmaceutical Processes and Their Demands

    Girish Malhotra, EPCOT International||April 5, 2016
    A look at the unique characteristics of continuous processes in pharmaceutical manufacturing.

  • Solid Dispersions

    Solid Dispersions

    Robert Harris, Juniper Pharma Services||April 5, 2016
    A universal formulation strategy for poorly soluble drugs?